Stay updated on Moderna Press Releases
Sign up to get notified when there's something new on the Moderna Press Releases page.

Latest updates to the Moderna Press Releases page
- Check5 days agoChange DetectedThe Moderna stock quote in the page header changed from $190.01 with 10.29M volume to $225.00 with 28.95M volume.SummaryDifference0.4%

- Check12 days agoChange DetectedThe press-release listing now features Moderna’s September 30, 2026 announcement about adding a Chief Operating Officer role amid its expansion into oncology; the July 16, 2026 clinical-trial announcement is no longer listed.SummaryDifference1%

- Check19 days agoChange DetectedNew press releases and stock data were added to the News and Blog Posts page, including Phase 1 trial updates, regulatory approvals, and quarterly results through September 2026, along with updated stock price and trading volume.SummaryDifference7%

- Check26 days agoChange DetectedStock price (NASD: MRNA 154.04) and trading volume (20.24M) were added, and the News and Blog Posts list now includes a refreshed set of press releases with dates. The added headlines reflect recent company announcements across financial results, trials, and regulatory approvals.SummaryDifference8%

- Check34 days agoChange DetectedThe News and Blog Posts listing is trimmed significantly, removing a large set of past press releases and dates, leaving a much leaner archive on the page.SummaryDifference6%

- Check41 days agoChange DetectedThe page now shows the latest stock price of $145.55 and trading volume of 14.97M, and adds a September 1, 2026 press release titled 'Moderna to Present at Upcoming Conferences in September 2026'. It also removes the prior stock data of $137.99 and 25.82M and the July 8, 2026 press release about Michael McDonnell's board appointment.SummaryDifference1%

Stay in the know with updates to Moderna Press Releases
Enter your email address, and we'll notify you when there's something new on the Moderna Press Releases page.